AstraZeneca to stop developing Crohn’s disease drug
British drugmaker AstraZeneca said on Thursday (June 1) it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative...
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc